Literature DB >> 1602537

The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.

G P Harrison1, A M Lever.   

Abstract

Interaction of cis-acting RNA sequences with nucleocapsid proteins is one of the critical events leading to retroviral genomic RNA packaging. We have derived a potentially stable secondary structure for the packaging signal region of human immunodeficiency virus strain IIIB, using a combination of biochemical analysis and computer modelling. This region encompasses the major splice donor (SD), which is found in a highly structured conserved stem-loop. Comparison with other published human immunodeficiency virus type 1 sequences shows almost absolute nucleotide conservation in base-paired regions required to maintain this structure. Presently and previously described packaging-defective mutants would disrupt the structure. The structure depends on base pairing between nucleotide sequences 5' of the major SD which are common to both genomic and subgenomic RNAs and sequences 3' of SD which are unique to the unspliced RNA. This may explain how in retroviruses such as Rous sarcoma virus, mutations in regions common to genomic and subgenomic RNA might prevent packaging of the unspliced mRNA by disrupting a signal structure which can exist only in the genomic RNA species.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602537      PMCID: PMC241217     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV.

Authors:  C Roy; N Tounekti; M Mougel; J L Darlix; C Paoletti; C Ehresmann; B Ehresmann; J Paoletti
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

2.  A comparison of optimal and suboptimal RNA secondary structures predicted by free energy minimization with structures determined by phylogenetic comparison.

Authors:  M Zuker; J A Jaeger; D H Turner
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

3.  Dimerization of human immunodeficiency virus (type 1) RNA: stimulation by cations and possible mechanism.

Authors:  R Marquet; F Baudin; C Gabus; J L Darlix; M Mougel; C Ehresmann; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 4.  Retroviral RNA packaging.

Authors:  A M Lever; J H Richardson; G P Harrison
Journal:  Biochem Soc Trans       Date:  1991-11       Impact factor: 5.407

5.  RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus.

Authors:  R L Alford; S Honda; C B Lawrence; J W Belmont
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

Review 6.  Posttranscriptional regulatory mechanisms in Escherichia coli.

Authors:  L Gold
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

7.  A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging.

Authors:  R A Katz; R W Terry; A M Skalka
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

8.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.

Authors:  M Linial; E Medeiros; W S Hayward
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

9.  Enzymatic and chemical structure mapping of mouse 28S ribosomal ribonucleic acid contacts in 5.8S ribosomal ribonucleic acid.

Authors:  T A Walker; K D Johnson; G J Olsen; M A Peters; N R Pace
Journal:  Biochemistry       Date:  1982-05-11       Impact factor: 3.162

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  110 in total

1.  Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

Authors:  C Liang; L Rong; Y Quan; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

5.  Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.

Authors:  Rodney S Russell; Jing Hu; Véronique Bériault; Andrew J Mouland; Michael Laughrea; Lawrence Kleiman; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.

Authors:  C Van Lint; C A Amella; S Emiliani; M John; T Jie; E Verdin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

7.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

8.  A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity.

Authors:  J L Clever; R A Taplitz; M A Lochrie; B Polisky; T G Parslow
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.

Authors:  Helga Bjarnadottir; Bjarki Gudmundsson; Janus Gudnason; Jon J Jonsson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

10.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.